Chronic hepatitis C: Treat or wait? Medical decision making in clinical practice

par Niederau, Claus, Hüppe, Dietrich, Zehnter, Elmar, Möller, Bernd, Heyne, Renate, Christensen, Stefan, Pfaff, Rainer, Theilmeier, Arno, Alshuth, Ulrich, Mauss, Stefan
Publié 2012

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

par Roeder, Claudia, Jordan, Sabine, Schulze zur Wiesch, Julian, Pfeiffer-Vornkahl, Heike, Hueppe, Dietrich, Mauss, Stefan, Zehnter, Elmar, Stoll, Sabine, Alshuth, Ulrich, Lohse, Ansgar W, Lueth, Stefan
Publié 2014

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

par Hofmann, Wolf Peter, Mauss, Stefan, Lutz, Thomas, Schober, Andreas, Böker, Klaus, Moog, Gero, Baumgarten, Axel, Pfeiffer-Vornkahl, Heike, Alshuth, Ulrich, Hüppe, Dietrich, Wedemeyer, Heiner, Manns, Michael P., Schott, Eckart
Publié dans PLoS One (2015)

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3

par Niederau, Claus, Mauss, Stefan, Schober, Andreas, Stoehr, Albrecht, Zimmermann, Tim, Waizmann, Michael, Moog, Gero, Pape, Stefan, Weber, Bernd, Isernhagen, Konrad, Sandow, Petra, Bokemeyer, Bernd, Alshuth, Ulrich, Steffens, Hermann, Hüppe, Dietrich
Publié 2014

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

par Marcellin, Patrick, Xie, Qing, Woon Paik, Seung, Flisiak, Robert, Piratvisuth, Teerha, Petersen, Jörg, Asselah, Tarik, Cornberg, Markus, Ouzan, Denis, Foster, Graham R., Papatheodoridis, Georgios, Messinger, Diethelm, Regep, Loredana, Bakalos, Georgios, Alshuth, Ulrich, Lampertico, Pietro, Wedemeyer, Heiner
Publié dans PLoS One (2020)